RAPP NASDAQ
Rapport Therapeutics, Inc. Common Stock
1W: -3.3%
1M: -0.2%
3M: +23.3%
YTD: +30.6%
1Y: +259.1%
$37.72
+1.02 (+2.78%)
Weekly Expected Move ±7.8%
$31
$34
$37
$40
$43
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$20M
Revenue
+0.0% YoY
$-107M
Net Income
-34.6% YoY
$-81M
Free Cash Flow
-16.6% YoY
98.9%
Gross Margin
-121.1%
Op. Margin
-99.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-27.2%
ROA-25.9%
ROIC-1724.6%
Valuation
P/E-16.6
P/B3.8
EV/EBITDA-8.5
Leverage
Debt/Equity0.02
Current Ratio26.17
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z31.68
Beneish M0.00